Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lysophosphatidylcholine as a ligand for immunoregulation.

Janusz H S Kabarowski1, Yan Xu, Owen N Witte

  • 1Department of Microbiology, Immunology & Molecular Genetics, University of California-Los Angeles, 5-748 MRL, 675 Charles E. Young Drive South, Box 951662, Los Angeles, CA 90095-1662, USA. januszk@microbio.ucla.edu

Biochemical Pharmacology
|July 19, 2002
PubMed
Summary

Lysophosphatidylcholine modulates immune responses by interacting with the G2A receptor, a G protein-coupled receptor. Its genetic absence leads to inflammatory autoimmune disease, highlighting its critical role in immune regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering.

Science (New York, N.Y.)·2026
Same author

Systematic mapping of emergent transcriptional states in interacting single-cell dyads by Cell-Cell-seq.

bioRxiv : the preprint server for biology·2026
Same author

OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance.

Molecular cancer research : MCR·2026
Same author

David Baltimore (1938-2025).

Nature biotechnology·2025
Same author

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

NPJ precision oncology·2025

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Lysophosphatidylcholine (LPC) is known to affect immune cells and inflammation, but its precise mechanism of action is unclear.
  • The identification of G2A as the first LPC receptor offers a new perspective on LPC's role in immune modulation.

Purpose of the Study:

  • To discuss the biological properties of lysophosphatidylcholine as an immunoregulatory ligand.
  • To explore the interaction of LPC with its receptor G2A and potential functional redundancy with other receptors.

Main Methods:

  • Literature review and commentary on existing research.
  • Focus on ligand interactions with the G2A receptor.

Main Results:

  • G2A is identified as an immunoregulatory G protein-coupled receptor for lysophosphatidylcholine.

Related Experiment Videos

  • Genetic ablation of G2A leads to the development of inflammatory autoimmune disease.
  • LPC acts as an immunoregulatory ligand for both innate and adaptive immune cells.

    • Conclusions:

    • Lysophosphatidylcholine plays a significant role in modulating immune responses through receptors like G2A.
    • Understanding LPC-G2A interactions is crucial for developing strategies against inflammatory autoimmune diseases.
    • Potential functional redundancy with other receptors for phosphorylcholine-containing lysolipids warrants further investigation.